Your browser doesn't support javascript.
loading
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose flux.
Ilina, Elena I; Armento, Angela; Sanchez, Leticia Garea; Reichlmeir, Marina; Braun, Yannick; Penski, Cornelia; Capper, David; Sahm, Felix; Jennewein, Lukas; Harter, Patrick N; Zukunft, Sven; Fleming, Ingrid; Schulte, Dorothea; Le Guerroué, Francois; Behrends, Christian; Ronellenfitsch, Michael W; Naumann, Ulrike; Mittelbronn, Michel.
Afiliación
  • Ilina EI; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt, Germany.
  • Armento A; Luxembourg Centre of Neuropathology (LCNP), 3555 Dudelange, Luxembourg.
  • Sanchez LG; NORLUX Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), 1526 Luxembourg, Luxembourg.
  • Reichlmeir M; Molecular Neurooncology, Department of Vascular Neurology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, 72076 Tübingen, Germany.
  • Braun Y; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt, Germany.
  • Penski C; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt, Germany.
  • Capper D; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt, Germany.
  • Sahm F; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt, Germany.
  • Jennewein L; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Harter PN; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Zukunft S; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, 69120 Heidelberg, Germany.
  • Fleming I; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Schulte D; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, 69120 Heidelberg, Germany.
  • Le Guerroué F; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt, Germany.
  • Behrends C; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt, Germany.
  • Ronellenfitsch MW; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Naumann U; Institute for Vascular Signaling, Centre for Molecular Medicine, Goethe University, 60590 Frankfurt, Germany.
  • Mittelbronn M; Institute for Vascular Signaling, Centre for Molecular Medicine, Goethe University, 60590 Frankfurt, Germany.
Oncotarget ; 8(40): 67567-67591, 2017 Sep 15.
Article en En | MEDLINE | ID: mdl-28978054
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos